J. Goldman & CO LP Biotechnology

J. Goldman & CO LP

  • $3.8 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$9.72 Million
36K
Q1 2025
New holding
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$5.67 Million
21K
Q1 2025
New holding
AXSM
Axsome Therapeutics, Inc.
CALL
$3.97 Million
34K
Q1 2025
Reduced 94.31%
VRNA
Verona Pharma PLC
PUT
$2.58 Million
40.6K
Q1 2025
Added 59.25%
INSM
Insmed Inc
PUT
$2.29 Million
30K
Q4 2024
Added 828.02%
PTGX
Protagonist Therapeutics, Inc
CALL
$2.06 Million
42.6K
Q1 2025
New holding
CNTA
Centessa Pharmaceuticals PLC
PUT
$1.36 Million
94.6K
Q1 2025
Reduced 17.02%
QURE
Uni Qure N.V.
PUT
$1.36 Million
128K
Q1 2025
Added 150.49%
SRPT
Sarepta Therapeutics, Inc.
CALL
$1.28 Million
20K
Q4 2024
Reduced 11.46%
MGTX
Meira G Tx Holdings PLC
CALL
$1.04 Million
154K
Q1 2025
Added 110.48%
ARQT
Arcutis Biotherapeutics, Inc.
CALL
$933,000
59.7K
Q1 2025
Reduced 70.53%
RPRX
Royalty Pharma PLC
PUT
$846,000
27.2K
Q1 2024
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$811,000
33.6K
Q4 2024
New holding
MLTX
Moon Lake Immunotherapeutics
CALL
$781,000
20K
Q1 2025
New holding
SWTX
Spring Works Therapeutics, Inc.
PUT
$600,000
13.6K
Q1 2025
Reduced 70.19%
QURE
Uni Qure N.V.
CALL
$572,000
54K
Q1 2025
Added 150.49%
IMVT
Immunovant, Inc.
PUT
$561,000
20.4K
Q1 2025
Reduced 38.84%
RNA
Avidity Biosciences, Inc.
CALL
$401,000
13.6K N/A
IMTX
Immatics N.V.
CALL
$121,000
27K
Q3 2024
Reduced 22.85%
JAZZ
Jazz Pharmaceuticals PLC
PUT
$86,000
700
Q3 2024
Reduced 75.33%
Filter Shares Options
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email